KEVIN GAREY to United States
This is a "connection" page, showing publications KEVIN GAREY has written about United States.
Connection Strength
0.293
-
Antibiotic utilization within 18 community hospitals in the United States: A 5-year analysis. Pharmacoepidemiol Drug Saf. 2021 04; 30(4):403-408.
Score: 0.062
-
Prevalence and predictors of spontaneous bacterial peritonitis due to ceftriaxone-resistant organisms at a large tertiary centre in the USA. J Glob Antimicrob Resist. 2018 12; 15:41-47.
Score: 0.052
-
Effect of a Health Care System Respiratory Fluoroquinolone Restriction Program To Alter Utilization and Impact Rates of Clostridium difficile Infection. Antimicrob Agents Chemother. 2017 06; 61(6).
Score: 0.049
-
Education, training, and academic experience of newly hired, first-time pharmacy faculty members. Am J Pharm Educ. 2014 Jun 17; 78(5):92.
Score: 0.040
-
Economic healthcare costs of Clostridium difficile infection: a systematic review. J Hosp Infect. 2010 Apr; 74(4):309-18.
Score: 0.030
-
Inadequacy of fluconazole dosing in patients with candidemia based on Infectious Diseases Society of America (IDSA) guidelines. Pharmacoepidemiol Drug Saf. 2007 Aug; 16(8):919-27.
Score: 0.025
-
Surveillance of Clostridioides difficile Antimicrobial Resistance in the United States. Clin Infect Dis. 2023 06 08; 76(11):2038-2039.
Score: 0.019
-
A multisite genomic epidemiology study of Clostridioides difficile infections in the USA supports differential roles of healthcare versus community spread for two common strains. Microb Genom. 2021 06; 7(6).
Score: 0.016